ZBIO
Zenas BioPharma·NASDAQ
--
--(--)
--
--(--)
ZBIO Filings
Filing Date
Form Description
Form Type
2026-04-01
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-01 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-31
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-31 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-31
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-31 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-31
Form 8-K - Current report
Key Events
2026-03-31 · Key Events
Form 8-K - Current report
2026-03-30
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-30 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-30
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-30 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-27
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-03-27 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-03-27
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-03-27 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-03-26
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-26 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-26
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-26 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
